Search research articles
Contact Us
Filters
Showing results (361-370 of 440) with videos related to
Page
of 44
Sort By:
Trials
|
October 11, 2023
e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidence
E J Mitchell, D Appelbe, A Bravery, et al.
British Journal of Cancer
|
July 1, 2017
Embracing model-based designs for dose-finding trials
Sharon B Love, Sarah Brown, Christopher J Weir, et al.
Journal of the American Chemical Society
|
March 5, 2013
Oxo-functionalization and reduction of the uranyl ion through lanthanide-element bond homolysis: synthetic, structural, and bonding analysis of a series of singly reduced uranyl-rare earth 5f1-4f(n) complexes
Polly L Arnold, Emmalina Hollis, Gary S Nichol, et al.
Trials
|
May 14, 2020
Access to routinely collected health data for clinical trials - review of successful data requests to UK registries
Sarah Lensen, Archie Macnair, Sharon B Love, et al.
The Journal of Biological Chemistry
|
May 23, 2012
Pin1 protein regulates Smad protein signaling and pulmonary fibrosis
Zhong-Jian Shen, Ruedi K Braun, Jie Hu, et al.
Surgery
|
October 18, 2011
The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation
P Marco Fisichella, Christopher S Davis, Peter W Lundberg, et al.
BMC Medical Research Methodology
|
January 20, 2019
How to design a dose-finding study using the continual reassessment method
Graham M Wheeler, Adrian P Mander, Alun Bedding, et al.
Inorganic Chemistry
|
June 4, 2016
A Comparison of the Selectivity of Extraction of [PtCl6](2-) by Mono-, Bi-, and Tripodal Receptors That Address Its Outer Coordination Sphere
Rebecca J Warr, Katherine J Bell, Anastasia Gadzhieva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
V Urbonas, D Schadendorf, L Zimmer, et al.
The New England Journal of Medicine
|
July 1, 2005
Daclizumab to prevent rejection after cardiac transplantation
Ray E Hershberger, Randall C Starling, Howard J Eisen, et al.
Page
of 44
Search research articles
Search
Showing results (361-370 of 440) with videos related to
Sort By:
Page
of 44
Trials
|
October 11, 2023
e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidence
E J Mitchell, D Appelbe, A Bravery, et al.
British Journal of Cancer
|
July 1, 2017
Embracing model-based designs for dose-finding trials
Sharon B Love, Sarah Brown, Christopher J Weir, et al.
Journal of the American Chemical Society
|
March 5, 2013
Oxo-functionalization and reduction of the uranyl ion through lanthanide-element bond homolysis: synthetic, structural, and bonding analysis of a series of singly reduced uranyl-rare earth 5f1-4f(n) complexes
Polly L Arnold, Emmalina Hollis, Gary S Nichol, et al.
Trials
|
May 14, 2020
Access to routinely collected health data for clinical trials - review of successful data requests to UK registries
Sarah Lensen, Archie Macnair, Sharon B Love, et al.
The Journal of Biological Chemistry
|
May 23, 2012
Pin1 protein regulates Smad protein signaling and pulmonary fibrosis
Zhong-Jian Shen, Ruedi K Braun, Jie Hu, et al.
Surgery
|
October 18, 2011
The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation
P Marco Fisichella, Christopher S Davis, Peter W Lundberg, et al.
BMC Medical Research Methodology
|
January 20, 2019
How to design a dose-finding study using the continual reassessment method
Graham M Wheeler, Adrian P Mander, Alun Bedding, et al.
Inorganic Chemistry
|
June 4, 2016
A Comparison of the Selectivity of Extraction of [PtCl6](2-) by Mono-, Bi-, and Tripodal Receptors That Address Its Outer Coordination Sphere
Rebecca J Warr, Katherine J Bell, Anastasia Gadzhieva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
V Urbonas, D Schadendorf, L Zimmer, et al.
The New England Journal of Medicine
|
July 1, 2005
Daclizumab to prevent rejection after cardiac transplantation
Ray E Hershberger, Randall C Starling, Howard J Eisen, et al.
Page
of 44